A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The drug performed better than placebo on clinical, symptomatic, endoscopic and histologic endpoints regardless of previous failure to TNF inhibitors ... of the drug in psoriasis, saying the ...

Turmeric and curcumin are among the most powerful natural anti-inflammatory agents, offering benefits for joint health, brain ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

UCB SA (OTCMKTS:UCBJF – Get Free Report)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $192.24 and traded as high as ...